{"AllianceGenome": "3801", "HGNC": "3801", "MIM": "602402", "_id": "2303", "_version": 1, "accession": {"genomic": ["AC009108.10", "CH471114.2", "CP068262.2", "GQ282998.1", "JQ664711.1", "JQ664712.1", "JQ664713.1", "JQ664714.1", "JQ664715.1", "JQ664716.1", "NC_000016.10", "NC_060940.1", "NG_012025.2", "Y08223.1"], "protein": ["AAI13438.1", "AAI13440.1", "ACS83751.1", "AFN73236.1", "AFN73237.1", "AFN73238.1", "AFN73239.1", "AFN73240.1", "AFN73241.1", "CAA69400.1", "EAW95415.1", "EAW95416.1", "NP_005242.1", "Q99958.1"], "rna": ["BC113437.1", "BC113439.1", "NM_005251.3"], "translation": [{"protein": "NP_005242.1", "rna": "NM_005251.3"}, {"protein": "AAI13440.1", "rna": "BC113439.1"}, {"protein": "AAI13438.1", "rna": "BC113437.1"}]}, "alias": ["FKHL14", "LD", "MFH-1", "MFH1"], "clingen": {"_license": "https://www.clinicalgenome.org/docs/terms-of-use/", "clinical_validity": {"classification": "definitive", "classification_date": "2024-01-24T17:00:00.000Z", "disease_label": "lymphedema-distichiasis syndrome", "gcep": "Prenatal Gene Curation Expert Panel", "moi": "AD", "mondo": "MONDO:0007922", "online_report": "https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_757840b2-8b39-44d0-aff9-dd9983e77d0f-2024-01-24T170000.000Z", "sop": "SOP10"}}, "ensembl": {"gene": "ENSG00000176692", "protein": "ENSP00000497759", "transcript": "ENST00000649859", "translation": [{"protein": "ENSP00000497759", "rna": "ENST00000649859"}], "type_of_gene": "protein_coding"}, "entrezgene": "2303", "exons": [{"cdsend": 86568841, "cdsstart": 86567335, "chr": "16", "position": [[86566828, 86569727]], "strand": 1, "transcript": "NM_005251", "txend": 86569727, "txstart": 86566828}], "exons_hg19": [{"cdsend": 86602447, "cdsstart": 86600941, "chr": "16", "position": [[86600434, 86603333]], "strand": 1, "transcript": "NM_005251", "txend": 86603333, "txstart": 86600434}], "generif": [{"pubmed": 11694548, "text": "FOXC2 mutations are highly penetrant with variable expressivity which is not explicable by the pattern of mutations."}, {"pubmed": 12114478, "text": "Analysis of phenotypic abnormalities in lymphedema-distichiasis syndrome patients with causative FOXC2 mutations suggests a possible developmental role for FOXC2 in both venous and lymphatic systems."}, {"pubmed": 12383817, "text": "Sequencing of the coding region of the only translated exon of the FOXC2 gene revealed a C to A transversion at position 939 resulting in a Tyr313Stop codon with premature termination of translation and a truncated protein product."}, {"pubmed": 12453913, "text": "Mutation screening of the FOXC2 gene identified a common polymorphism in the 5' untranslated region (C-512T). The T allele was associated with enhanced insulin sensitivity."}, {"pubmed": 12485195, "text": "An out-of-frame deletion (914-921del) was identified and found to segregate with distichiasis-lymphedema syndrome, further highlighting the phenotypic heterogeneity of lymphedema conditions linked to FOXC2 truncating mutations"}, {"pubmed": 12540636, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 12540636, "text": "absence of evidence for the association of three frequent single nucleotide polymorphisms and four common haplotypes with Japanese type 2 diabetes"}, {"pubmed": 12716768, "text": "Genetic variations of this protein occur in Pima Indians."}, {"pubmed": 12716768, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 14530861, "text": "FOXC2 -512C>T variant is not associated with Type 2 diabetes."}, {"pubmed": 14530861, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 15198934, "text": "adipose FOXC2 is more highly expressed in insulin-resistant subjects, and this effect is independent of obesity"}, {"pubmed": 15597109, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 15601967, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 15601967, "text": "data suggest that transcription factor FOXC2 is a weak but consistent candidate gene for obesity and dyslipidemia"}, {"pubmed": 15919786, "text": "These findings demonstrate an important role of adipocyte-expressed FOXC2 on whole-body glucose metabolism."}, {"pubmed": 15926113, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 16081467, "text": "FOXC2 missense mutations identified as functional nulls in patients with hereditary lymphedema with distichiasis."}, {"pubmed": 16456100, "text": "Foxc2 is a key molecule to regulate PAI-1 gene expression."}, {"pubmed": 16786163, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 16786163, "text": "Results suggest that FOXC2 is a susceptibility locus for reduced BMD in Japanese men and women."}, {"pubmed": 16952980, "text": "these data implicate specific members of the FOX family of TFs (FOXC1, C2, P1, P4, and O1A) not previously suggested in heart failure pathogenesis."}, {"pubmed": 17342473, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 17372167, "text": "Every participant with a mutation in FOXC2 showed reflux in the great saphenous vein. FOXC2 appears to be important for the normal development and maintenance of venous and lymphatic valves."}, {"pubmed": 17537911, "text": "FOXC2 plays a key role in metastasis and is associated with aggressive basal-like breast tumors."}, {"pubmed": 18197197, "text": "confirmation that of the primary lymphoedemas, only lymphoedema with distichiasis is caused by FOXC2 mutations [Fox2C]"}, {"pubmed": 18564920, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18660489, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18973153, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 18974842, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18986489, "text": "family with classical lymphedema-distichiasis syndrome caused by a duplication in the FOXC2-gene"}, {"pubmed": 19013876, "text": "lymphedema-distichiasis disorder is linked to a novel missense mutation in a patient"}, {"pubmed": 19056482, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19185813, "text": "Forkhead transcription factor Foxc2 directly regulates expression of genes involved in angiogenesis: CXCR4, integrin beta3, Delta-like 4 (Dll4), and angiopoietin 2. Foxc2 is a regulator of vascular formation and remodeling."}, {"pubmed": 19339011, "text": "Expression of FOXC2 was significantly decreased in three samples from familial combined hyperlipidaemia compared to controls."}, {"pubmed": 19394045, "text": "Mutations in the VEGFR3 and FOXC2 genes account for a subset of patients with unexplained in utero generalized subcutaneous edema and hydrops fetalis without family history of lymphedema"}, {"pubmed": 19453261, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19548265, "text": "Decreased FOXC2 expression were shown in the lymphatic endothelial cells of the jugular lymphatic sacs of the trisomic fetuses."}, {"pubmed": 19760751, "text": "The FOXC2 gene in 288 patients with primary lymphedema was analyzed and 11 pathogenic mutations, of which 9 are novel, were found."}, {"pubmed": 19876004, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19935708, "text": "Foxc2 may have regulatory functions independent of its nuclear transcriptional activity."}, {"pubmed": 20060810, "text": "these findings demonstrate that haplodeficiency of Foxc2 results in impaired formation of tumor blood vessels as well as reduced tumor growth and thereby provide evidence that Foxc2 is critical for tumor development and angiogenesis."}, {"pubmed": 20201926, "text": "Observational study and genome-wide association study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20218083, "text": "Chromosome 16 duplication upstream of FOXC2 is associated with lymphedema-distichiasis syndrome without FOXC2 mutation."}, {"pubmed": 20450314, "text": "Here we describe a case of lymphedema carrying a de novo frameshift mutation of FOXC2 who presented a prepubertal onset of lower limbs lymphedema and mild distichiasis associated with other anomalies such as webbing neck and ptosis."}, {"pubmed": 20460685, "text": "FOXC2 mediates the transcriptional repression of p120 catenin in non-small cell lung cancer cells."}, {"pubmed": 20535019, "text": "The Q100X mutation in FOXC2 is the genetic defect underlying the lymphedema-distichiasis syndrome in a family that also exhibits high prevalence of spinal extradural arachnoid cysts."}, {"pubmed": 20540670, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20552815, "text": "A novel missense mutation and two microrearrangements in the FOXC2 gene of three families with lymphedema-distichiasis syndrome."}, {"pubmed": 20634891, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20803080, "text": "High-FOXC2 expression is associated with esophageal squamous cell carcinoma."}, {"pubmed": 21270254, "text": "the current findings identify a previously unknown role for Foxc2 as an important metabo-regulator of mitochondrial morphology and metabolism."}, {"pubmed": 21457232, "text": "de novo mutations and rare variants in hypoplastic left heart syndrome for FOXC2 gene"}, {"pubmed": 21464574, "text": "FOXC2 mutations cause a functional failure of dermal initial lymphatics during gravitational stress (dependency), but not hypoplasia."}, {"pubmed": 21640215, "text": "Results indicate that Foxc2 plays an important role in osteoblastogenesis by promoting osteoblast proliferation, survival and differentiation through up-regulation of integrin beta1 in response to stimuli which induce bone formation."}, {"pubmed": 21918810, "text": "This family study illustrates that a hereditary form of lymphedema, caused by a FOXC2 mutation, can cause severe hydrops fetalis and neonatal pulmonary lymphangiectasis."}, {"pubmed": 22178381, "text": "Increased expression of Foxc2 was observed in 27.7% of primary NSCLC tumors. Overexpression of Foxc2 in stage I NSCLC was associated with a worse overall survival and correlated with a shorter recurrence-free survival."}, {"pubmed": 22216698, "text": "FOXC2 expression was significantly correlatd with the degree of lymph node metastasis in colorectal cancer."}, {"pubmed": 22349027, "text": "describe three generations of a family with lymphedema-distichiasis syndrome. The mutation is a frameshift due to a deletion of two nucleotides in C repeats between C586 and C591, leading to protein truncation from an earlier insertion of a stop codon."}, {"pubmed": 22374725, "text": "Nuclear localization of GLI1 and elevated expression of FOXC2 in breast cancer is associated with the basal-like phenotype."}, {"pubmed": 22410781, "text": "Resveratrol inhibited the expression of FOXC2 through regulation of miRNA-520h-mediated signal cascade."}, {"pubmed": 22493429, "text": "findings demonstrate that SC motifs mediate the inhibitory function of this region by serving as sites for SUMOylation and reveal a novel mechanism for acute and reversible regulation of FOXC1/C2 function"}, {"pubmed": 23378344, "text": "FOXC2 or its associated gene expression program may provide an effective target for anti-EMT-based therapies for the treatment of claudin-low/basal B breast tumors or other EMT-/CSC-enriched tumors"}, {"pubmed": 23614500, "text": "FoxC2 and p120ctn play important roles in the progression and prognosis of gastric cancer."}, {"pubmed": 23878394, "text": "Results indicate the pivotal role of phosphorylation in the regulation of FOXC2-mediated transcription in lymphatic endothelial cells."}, {"pubmed": 23919841, "text": "FOXC2 contributes to a poor prognosis and cancer progression in extrahepatic cholangiocarcinoma."}, {"pubmed": 24276887, "text": "FOXC2 is indispensable for all stages of lymphatic valve development [review]"}, {"pubmed": 24278289, "text": "Seven sporadic SEDAC subjects had no FOXC2 mutations, no symptoms of LDS, and showed differing clinical characteristics from those who had FOXC2 mutations, suggesting that other gene(s) besides FOXC2 are likely to be involved in SEDAC"}, {"pubmed": 24641373, "text": "FOXC2 gene expression increases with malignancy, especially with blood vessel hyperplasia and invasion degree. Targeted silencing was associated with reduced cell proliferation as well as invasion potential."}, {"pubmed": 24647631, "text": "Results suggested that Prox1 and FOXC2 play key roles in OSCC progression and that further studies focusing on these proteins may yield useful insights for diagnosis and therapy of OSCC."}, {"pubmed": 24700112, "text": "FOXC2 or its associated gene expression program may provide an effective target for anti-EMT-based therapies"}, {"pubmed": 24700685, "text": "The study defines the requirement of FOXC2 for phosphate-induced osteopontin (OPN) expression and secretion from cancer cells as necessary for the angiogenic response."}, {"pubmed": 24984567, "text": "we found a novel missense mutation of C.370C>T in a family with lymphoedema-distichiasis syndrome, which caused an amino acid change from leucine to phenylalanine (p.Leu124Phe)."}, {"pubmed": 25109336, "text": "Results show that GD3S regulates stem cell function via c-Met and the expression of GD3S is regulated by FOXC2, a transcription factor functioning downstream of several epithelial-mesenchymal transition signaling pathways."}, {"pubmed": 25216525, "text": "SENP3, which is increased in gastric cancer cells, potentiates the transcriptional activity of FOXC2 through de-SUMOylation, in favor of the induction of specific mesenchymal gene expression in gastric cancer metastasis."}, {"pubmed": 25381815, "text": "FOXC2 expression was positively correlated with MET expression in CRC tissue samples."}, {"pubmed": 25480587, "text": "It was concluded that there is a significant association between FOXC2 and the metastasis of invasive breast cancer."}, {"pubmed": 25486430, "text": "we propose that Foxc2 is functionally maintained in the cytoplasm of normal epithelial cells by CK2alpha/alpha'-mediated phosphorylation at serine 124, which is dependent on proper targeting of the holoenzyme via the CK2b regulatory subunit."}, {"pubmed": 25556265, "text": "FOXC2 may promote the development of cervical cancer via regulation of angiogenesis."}, {"pubmed": 25573594, "text": "High FOXC2 expression is associated with tumor proliferation and invasion potential in oral tongue squamous cell carcinoma."}, {"pubmed": 25605149, "text": "High expression of forkhead box protein C2 is related to gliomas."}, {"pubmed": 25677742, "text": "Twist and Foxc2 stromal expression in PTs was significantly correlated with tumour grade and worse histological features."}, {"pubmed": 25896630, "text": "targeting FOXC2 may provide a novel strategy for overcoming chemoresistance in nasopharyngeal carcinoma therapy."}, {"pubmed": 26091406, "text": "our findings contribute to the putative targets in which the FLT4 gene mutation was found to have a significant role in lymphatic filariasis, while FOXC2 and FLT4 SNP interactions need to be further elucidated at a functional level."}, {"pubmed": 26125751, "text": "Peri-tumoral lymphatics were associated with increased lymphatic metastasis. FOXC2 may be associated with the genesis of endometrial carcinoma and lymphangiogensis in endometrial adenocarcinoma in intra- and peri-tumoral lymphatics."}, {"pubmed": 26389677, "text": "In cultured lymphatic endothelial cells, FOXC2 inactivation conferred abnormal shear stress sensing, promoting junction disassembly and entry into the cell cycle.  This was mediated by TAZ and led to cell death."}, {"pubmed": 26420053, "text": "Association of polymorphisms near the FOXC2 gene with the risk of varicose veins in ethnic Russians."}, {"pubmed": 26524507, "text": "The data indicate that the expression of FOXC2 in podocytes needs to be tightly regulated, and that its overexpression induces a chain of cellular events leading to podocyte dysfunction."}, {"pubmed": 26733175, "text": "High expression of FOXC2 is associated with pancreatic ductal adenocarcinoma."}, {"pubmed": 26758745, "text": "Evaluation of FoxC2 expression, alone or in combination with E-cadherin expression, may help to stratify non-small cell lung cancer patients for risk of disease progression, pointing to this EMT regulator as a potential prognostic marker"}, {"pubmed": 26804168, "text": "we demonstrate that FOXC2 is an important determinant of PCa stem-cell attributes, dictating the biochemical shift to ADT- and chemo-resistance"}, {"pubmed": 26808710, "text": "Data indicate the role for altered forkhead box C2 (FoxC2)-Delta-like ligand 4 (Dll4)signaling in structural alterations of saphenous veins in patients with varicose veins."}, {"pubmed": 26824865, "text": "Adenovirus-mediated FoxC2 expression enhances BMP7-facilitated anabolism in nucleus pulposus cells of the intervertebral discs."}, {"pubmed": 27064522, "text": "Moreover, PLK1 activity is important for FOXC2 protein stability, since PLK1 inhibition reduces FOXC2 protein levels."}, {"pubmed": 27214551, "text": "FOXC1 and FOXC2 are essential regulators of lymphangiogenesis and may have roles in lymphatic-associated diseases"}, {"pubmed": 27276711, "text": "either a complete loss or a significant gain of FOXC2 function can cause a perturbation of lymphatic vessel formation leading to lymphedema."}, {"pubmed": 27283491, "text": "FOXC2 and CLIP4 activity correlates to the presence of </=7-cm clear cell renal cell carcinomas (ccRCCs) with synchronous metastasis and may be potential molecular predictors of synchronous metastasis of </=7-cm ccRCCs."}, {"pubmed": 27292262, "text": "our data demonstrate that FOXC2 regulates EMT, stem cell traits, ZEB1 expression and metastasis in a p38-dependent manner, and attest to the potential utility of p38 inhibitors as antimetastatic agents."}, {"pubmed": 27336949, "text": "Data suggest that forkhead box protein C2 (FOXC2) could be a potential therapeutic target for overcoming cisplatin (CDDP) resistance in ovarian cancer."}, {"pubmed": 27349002, "text": "FOXC2 gene is associated with the glycolipid metabolic abnormality in T2DM patients."}, {"pubmed": 27562816, "text": "FOXC2 promotes epithelial-mesenchymal transition, migration and invasion in cisplatin-resistant human ovarian cancer cells."}, {"pubmed": 27570485, "text": "This is the first report of a FOXC2 mutation in hereditary distichiasis in the Chinese population. The findings expand the FOXC2 mutation spectrum and contribute to the understanding of the genotype-phenotype correlation of this disease."}, {"pubmed": 27634875, "text": "In FOXC2 knockdown cell lines, CXCR4, a downstream target of FOXC2, can restore osteosarcoma cell invasiveness and metastasis to the lung"}, {"pubmed": 28323030, "text": "Authors concluded that the lncRNA FOXC2-AS1 may promote doxorubicin resistance in OS by increasing the expression of transcription factor FOXC2, further facilitating ABCB1 expression."}, {"pubmed": 28433696, "text": "FOXC2 promoted the glycolysis in progression of nasopharyngeal carcinoma by activating YAP signaling"}, {"pubmed": 28544699, "text": "respectively. Foxc2 is expressed in the developing kidney and therefore congenital renal anomalies may well be associated, potentially as a low penetrance feature. We propose that all individuals diagnosed with Lymphedema distichiasis syndrome should have a baseline renal ultrasound scan at diagnosis"}, {"pubmed": 28657660, "text": "Genomic analysis of blood and excised valve tissue showed down-regulation of FOXC1 but also FOXC2 expression in the diseased aortic valve. This allows us to speculate on the potential role of FOXC1 in aortic valve anomalies."}, {"pubmed": 28724617, "text": "The expression of the transcription factors Foxc2 and Nfatc1 and the gap junction proteins Gjc2, Gja1, and Gja4 were temporospatially regulated during this process."}, {"pubmed": 29131008, "text": "Knockdown of FOXC2 inhibited HCC cell growth, migration, and invasion in vitro, as well as tumor growth."}, {"pubmed": 29216867, "text": "Studied interactions between protein kinase C alpha (PKCalpha), FOXC2, and p120-catenin (CTNND1) in breast cancer, cell migration/ invasion; found PKCalpha acts as an upstream regulator of FOXC2, which in turn represses the expression of p120-catenin, in both in endocrine resistant ER+breast cancer and basal A triple negative breast cancer."}, {"pubmed": 29341903, "text": "REVIEW: current understanding of FOXC2 and provide potential mechanistic explanations of the relationship between FOXC2 and cancer, as well as discuss the prospect for future research in the promising prognostic value of FOXC2 in cancer"}, {"pubmed": 29465790, "text": "that FOXC2 could promote the invasion ability of normal trophoblast cells by epithelial-mesenchymal transition -mediated Hedgehog pathway"}, {"pubmed": 29737063, "text": "FOXC-2 and YB-1 may be related to the occurrence, development, invasion and metastasis of gastric carcinoma."}, {"pubmed": 29801468, "text": "The high expression of FOXC2 in hepatocellular carcinoma (HCC) is correlated with tumor malignancy and poor prognosis, suggesting that FOXC2 may be an important prognostic factor for HCC."}, {"pubmed": 29908552, "text": "The finding of rare LAMA5 variants together with FOXC2 mutations in lymphedema-distichiasis syndrome suggests that these mutations may be co-responsible for these disorders and most likely interfere with the function of lymphatics."}, {"pubmed": 30633332, "text": "H19 and Foxc2 synergistically promoted osteogenic differentiation of bone marrow mesenchymal stem cells via Wnt-beta-catenin pathway"}, {"pubmed": 30657791, "text": "the increased frequency in PCG patients of rare FOXC2 and PITX2 variants with mild functional alterations, suggests they play a role as putative modifier factors in this disease further supporting that Congenital glaucoma (CG) is not a simple monogenic disease and provides novel insights into the complex pathological mechanisms that underlie CG."}, {"pubmed": 30722065, "text": "our structural analysis and accompanying biochemical assays provide a molecular basis for understanding disease-causing mutations in FOXC1 and FOXC2"}, {"pubmed": 30994379, "text": "Foxc2 attenuated adhesion of THP-1 cells to human umbilical vein endothelial cells by suppressing ICAM-1 expression."}, {"pubmed": 31464093, "text": "we have demonstrated that FOXC2 is strongly expressed in primary, metastatic and castration resistant prostate cancers, and is a strong predictor of outcome, of potential importance for prognostication and targeted therapy."}, {"pubmed": 31531679, "text": "The expression pattern of FOXC2 during podocyte differentiation seems to be affected by miR-548c-5p."}, {"pubmed": 32222147, "text": "Functional polymorphisms in FOXC2 gene and Epithelial ovarian Cancer susceptibility in Chinese population."}, {"pubmed": 32249539, "text": "Circular RNA PVT1 promotes metastasis via regulating of miR-526b/FOXC2 signals in OS cells."}, {"pubmed": 32271448, "text": "LncRNA FOXC2-AS1 regulated proliferation and apoptosis of vascular smooth muscle cell through targeting miR-1253/FOXF1 axis in atherosclerosis."}, {"pubmed": 32513911, "text": "LncRNA FOXC2-AS1 enhances FOXC2 mRNA stability to promote colorectal cancer progression via activation of Ca(2+)-FAK signal pathway."}, {"pubmed": 32698337, "text": "FOXC2 Disease Mutations Identified in Lymphedema Distichiasis Patients Impair Transcriptional Activity and Cell Proliferation."}, {"pubmed": 33107170, "text": "Lymphedema distichiasis syndrome may be caused by FOXC2 promoter-enhancer dissociation and disruption of a topological associated domain."}, {"pubmed": 33193083, "text": "The Effect of FOXC2-AS1 on White Adipocyte Browning and the Possible Regulatory Mechanism."}, {"pubmed": 33336729, "text": "MiR-1231 enhances docetaxel sensitivity to gallbladder carcinoma cells by downregulating FOXC2."}, {"pubmed": 33338479, "text": "Long non-coding RNA GClnc1 knockdown suppresses progression of epithelial ovarian cancer by recruiting FOXC2 to disrupt the NOTCH1/NF-kappaB/Snail pathway."}, {"pubmed": 33636524, "text": "The prognostic significance of FOXC2 gene expression in cancer: A comprehensive analysis of RNA-seq data from the cancer genome atlas."}, {"pubmed": 33771836, "text": "Super-Enhancer-Associated Transcription Factors Maintain Transcriptional Regulation in Mature Podocytes."}, {"pubmed": 33925370, "text": "Imbalance between Expression of FOXC2 and Its lncRNA in Lymphedema-Distichiasis Caused by Frameshift Mutations."}, {"pubmed": 34212977, "text": "MicroRNA199a5p regulates FOXC2 to control human vascular smooth muscle cell phenotypic switch."}, {"pubmed": 34324140, "text": "FOXC2-AS1 stabilizes FOXC2 mRNA via association with NSUN2 in gastric cancer cells."}, {"pubmed": 34656527, "text": "Digenic Inheritance of a FOXC2 Mutation and Two PIEZO1 Mutations Underlies Congenital Lymphedema in a Multigeneration Family."}, {"pubmed": 35532201, "text": "Forkhead box C2 is associated with insulin resistance in gestational diabetes mellitus."}, {"pubmed": 35716761, "text": "Genetic landscape of FOXC2 mutations in lymphedema-distichiasis syndrome: Different mechanism of pathogenicity for mutations in different domains."}, {"pubmed": 36740986, "text": "The FOXC2 Transcription Factor: A Master Regulator of Chemoresistance in Cancer."}, {"pubmed": 36805538, "text": "Up-regulation of microRNA-183 reduces FOXO1 expression in gastric cancer patients with Helicobacter pylori infection."}, {"pubmed": 37072887, "text": "Defects in vein valve PROX1/FOXC2 antithrombotic pathway in endothelial cells drive the hypercoagulable state induced by trauma and critical illness."}, {"pubmed": 37705741, "text": "FOXC2-AS1/FOXC2 axis mediates matrix stiffness-induced trans-differentiation of hepatic stellate cells into fibrosis-promoting myofibroblasts."}, {"pubmed": 38580085, "text": "Variants in FOXC1 and FOXC2 identified in patients with conotruncal heart defects."}, {"pubmed": 38608123, "text": "The role of transcription factor FOXA1/C2/M1/O3/P1/Q1 in breast cancer."}], "genomic_pos": {"chr": "16", "end": 86569728, "ensemblgene": "ENSG00000176692", "start": 86566829, "strand": 1}, "genomic_pos_hg19": {"chr": "16", "end": 86602539, "start": 86600857, "strand": 1}, "go": {"BP": [{"evidence": "ISS", "gocategory": "BP", "id": "GO:0000122", "qualifier": "involved_in", "term": "negative regulation of transcription by RNA polymerase II"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0001503", "qualifier": "involved_in", "term": "ossification"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0001569", "qualifier": "involved_in", "term": "branching involved in blood vessel morphogenesis"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0001656", "qualifier": "involved_in", "term": "metanephros development"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0001657", "qualifier": "involved_in", "term": "ureteric bud development"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0001756", "qualifier": "involved_in", "term": "somitogenesis"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0001946", "pubmed": 12114478, "qualifier": "involved_in", "term": "lymphangiogenesis"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0001974", "qualifier": "involved_in", "term": "blood vessel remodeling"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0003275", "qualifier": "involved_in", "term": "apoptotic process involved in outflow tract morphogenesis"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0006357", "qualifier": "involved_in", "term": "regulation of transcription by RNA polymerase II"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0007219", "qualifier": "involved_in", "term": "Notch signaling pathway"}, {"evidence": "NAS", "gocategory": "BP", "id": "GO:0007498", "pubmed": 8674414, "qualifier": "involved_in", "term": "mesoderm development"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0007507", "pubmed": 21457232, "qualifier": "involved_in", "term": "heart development"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0008286", "pubmed": 16456100, "qualifier": "involved_in", "term": "insulin receptor signaling pathway"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0009653", "qualifier": "involved_in", "term": "anatomical structure morphogenesis"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0009725", "pubmed": 16456100, "qualifier": "involved_in", "term": "response to hormone"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0010595", "qualifier": "involved_in", "term": "positive regulation of endothelial cell migration"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0014032", "qualifier": "involved_in", "term": "neural crest cell development"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0030154", "qualifier": "involved_in", "term": "cell differentiation"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0030199", "qualifier": "involved_in", "term": "collagen fibril organization"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0033630", "qualifier": "involved_in", "term": "positive regulation of cell adhesion mediated by integrin"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0035050", "qualifier": "involved_in", "term": "embryonic heart tube development"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0035470", "qualifier": "involved_in", "term": "positive regulation of vascular wound healing"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0043010", "qualifier": "involved_in", "term": "camera-type eye development"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0045893", "pubmed": [9169153, 16081467], "qualifier": "involved_in", "term": "positive regulation of DNA-templated transcription"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0045944", "pubmed": 20956529, "qualifier": "involved_in", "term": "positive regulation of transcription by RNA polymerase II"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0045944", "qualifier": "involved_in", "term": "positive regulation of transcription by RNA polymerase II"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0046620", "qualifier": "involved_in", "term": "regulation of organ growth"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0048010", "qualifier": "involved_in", "term": "vascular endothelial growth factor receptor signaling pathway"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0048343", "qualifier": "involved_in", "term": "paraxial mesodermal cell fate commitment"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0048703", "qualifier": "involved_in", "term": "embryonic viscerocranium morphogenesis"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0048844", "qualifier": "involved_in", "term": "artery morphogenesis"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0055010", "qualifier": "involved_in", "term": "ventricular cardiac muscle tissue morphogenesis"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0060038", "qualifier": "involved_in", "term": "cardiac muscle cell proliferation"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0072011", "qualifier": "involved_in", "term": "glomerular endothelium development"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0072112", "qualifier": "involved_in", "term": "podocyte differentiation"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0072144", "qualifier": "involved_in", "term": "glomerular mesangial cell development"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0090050", "qualifier": "involved_in", "term": "positive regulation of cell migration involved in sprouting angiogenesis"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0097746", "qualifier": "involved_in", "term": "blood vessel diameter maintenance"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0120163", "pubmed": 11551504, "qualifier": "involved_in", "term": "negative regulation of cold-induced thermogenesis"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:1902257", "qualifier": "involved_in", "term": "negative regulation of apoptotic process involved in outflow tract morphogenesis"}], "CC": [{"evidence": "ISA", "gocategory": "CC", "id": "GO:0000785", "qualifier": "part_of", "term": "chromatin"}, {"evidence": "IC", "gocategory": "CC", "id": "GO:0005634", "pubmed": 9169153, "qualifier": "located_in", "term": "nucleus"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005634", "pubmed": [11562355, 16081467], "qualifier": "located_in", "term": "nucleus"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005654", "qualifier": "located_in", "term": "nucleoplasm"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0016604", "qualifier": "located_in", "term": "nuclear body"}], "MF": [{"category": "MF", "evidence": "ISS", "id": "GO:0000976", "qualifier": "enables", "term": "transcription cis-regulatory region binding"}, {"category": "MF", "evidence": "IDA", "id": "GO:0000977", "pubmed": 20956529, "qualifier": "enables", "term": "RNA polymerase II transcription regulatory region sequence-specific DNA binding"}, {"category": "MF", "evidence": "IBA", "id": "GO:0000978", "qualifier": "enables", "term": "RNA polymerase II cis-regulatory region sequence-specific DNA binding"}, {"category": "MF", "evidence": "IDA", "id": "GO:0000978", "pubmed": 20956529, "qualifier": "enables", "term": "RNA polymerase II cis-regulatory region sequence-specific DNA binding"}, {"category": "MF", "evidence": "IBA", "id": "GO:0000981", "qualifier": "enables", "term": "DNA-binding transcription factor activity, RNA polymerase II-specific"}, {"category": "MF", "evidence": "ISA", "id": "GO:0000981", "qualifier": "enables", "term": "DNA-binding transcription factor activity, RNA polymerase II-specific"}, {"category": "MF", "evidence": "IDA", "id": "GO:0001216", "pubmed": 9169153, "qualifier": "enables", "term": "DNA-binding transcription activator activity"}, {"category": "MF", "evidence": "IDA", "id": "GO:0001228", "pubmed": 20956529, "qualifier": "enables", "term": "DNA-binding transcription activator activity, RNA polymerase II-specific"}, {"category": "MF", "evidence": "IPI", "id": "GO:0005515", "pubmed": [25416956, 32296183], "qualifier": "enables", "term": "protein binding"}, {"category": "MF", "evidence": "IDA", "id": "GO:0031490", "pubmed": 16456100, "qualifier": "enables", "term": "chromatin DNA binding"}, {"category": "MF", "evidence": "IPI", "id": "GO:0042802", "pubmed": 25609649, "qualifier": "enables", "term": "identical protein binding"}, {"category": "MF", "evidence": "IDA", "id": "GO:0043565", "pubmed": 16081467, "qualifier": "enables", "term": "sequence-specific DNA binding"}, {"category": "MF", "evidence": "IDA", "id": "GO:1990837", "pubmed": 28473536, "qualifier": "enables", "term": "sequence-specific double-stranded DNA binding"}, {"category": "MF", "evidence": "ISS", "id": "GO:1990841", "qualifier": "enables", "term": "promoter-specific chromatin binding"}]}, "homologene": {"genes": [[8364, 407875], [9031, 396039], [9544, 694852], [9598, 468058], [9606, 2303], [9615, 102153219], [9913, 507300], [10090, 14234], [10116, 171356]], "id": 21091}, "interpro": [{"desc": "Fork head domain", "id": "IPR001766", "short_desc": "Fork_head_dom"}, {"desc": "Fork head domain conserved site1", "id": "IPR018122", "short_desc": "TF_fork_head_CS_1"}, {"desc": "Fork head domain conserved site 2", "id": "IPR030456", "short_desc": "TF_fork_head_CS_2"}, {"desc": "Winged helix-like DNA-binding domain superfamily", "id": "IPR036388", "short_desc": "WH-like_DNA-bd_sf"}, {"desc": "Winged helix DNA-binding domain superfamily", "id": "IPR036390", "short_desc": "WH_DNA-bd_sf"}, {"desc": "Forkhead box protein C1/C2-like, forkhead domain", "id": "IPR047391", "short_desc": "FOXC1/C2-like_FH"}], "ipi": "IPI00019155", "map_location": "16q24.1", "name": "forkhead box C2", "other_names": ["MFH-1,mesenchyme forkhead 1", "forkhead box C2 (MFH-1, mesenchyme forkhead 1)", "forkhead box protein C2", "forkhead, Drosophila, homolog-like 14", "forkhead-related protein FKHL14", "mesenchyme fork head protein 1", "mesenchyme forkhead 1", "transcription factor FKH-14"], "pantherdb": {"HGNC": "3801", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "1347481", "ortholog_type": "LDO", "panther_family": "PTHR11829", "taxid": 10090, "uniprot_kb": "Q61850"}, {"RGD": "621703", "ortholog_type": "LDO", "panther_family": "PTHR11829", "taxid": 10116, "uniprot_kb": "Q63246"}, {"Ensembl": "ENSGALG00000043015", "ortholog_type": "O", "panther_family": "PTHR11829", "taxid": 9031, "uniprot_kb": "A0A1D5P3V5"}, {"ZFIN": "ZDB-GENE-010302-2", "ortholog_type": "O", "panther_family": "PTHR11829", "taxid": 7955, "uniprot_kb": "Q9DE24"}, {"ZFIN": "ZDB-GENE-010302-1", "ortholog_type": "O", "panther_family": "PTHR11829", "taxid": 7955, "uniprot_kb": "Q9DE25"}, {"FlyBase": "FBgn0014143", "ortholog_type": "O", "panther_family": "PTHR11829", "taxid": 7227, "uniprot_kb": "P32027"}, {"SGD": "S000001393", "ortholog_type": "O", "panther_family": "PTHR11829", "taxid": 4932, "uniprot_kb": "P40466"}, {"SGD": "S000000661", "ortholog_type": "O", "panther_family": "PTHR11829", "taxid": 4932, "uniprot_kb": "P25364"}, {"PomBase": "SPBC4C3.12", "ortholog_type": "O", "panther_family": "PTHR11829", "taxid": 4896, "uniprot_kb": "O43058"}, {"PomBase": "SPBC32H8.11", "ortholog_type": "O", "panther_family": "PTHR11829", "taxid": 4896, "uniprot_kb": "O13606"}], "uniprot_kb": "Q99958"}, "pathway": {"reactome": [{"id": "R-HSA-1266738", "name": "Developmental Biology"}, {"id": "R-HSA-9758941", "name": "Gastrulation"}, {"id": "R-HSA-9761174", "name": "Formation of intermediate mesoderm"}, {"id": "R-HSA-9830369", "name": "Kidney development"}, {"id": "R-HSA-9830674", "name": "Formation of the ureteric bud"}], "wikipathways": [{"id": "WP1591", "name": "Heart Development"}, {"id": "WP236", "name": "Adipogenesis"}, {"id": "WP2857", "name": "Mesodermal commitment pathway"}, {"id": "WP3927", "name": "BMP Signaling Pathway in Eyelid Development"}, {"id": "WP4239", "name": "Epithelial to mesenchymal transition in colorectal cancer"}, {"id": "WP4657", "name": "22q11.2 copy number variation syndrome"}, {"id": "WP4823", "name": "Genes controlling nephrogenesis"}, {"id": "WP4830", "name": "GDNF-RET signaling axis"}]}, "pdb": ["1D5V", "6AKO", "6AKP", "6LBM", "6O3T"], "pfam": "PF00250", "pharmgkb": "PA28218", "pharos": {"target_id": 1543, "tdl": "Tbio"}, "prosite": "PS50039", "reagent": {"GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF249451", "relationship": "is"}, {"id": "GNF249452", "relationship": "is"}, {"id": "GNF249453", "relationship": "is"}, {"id": "GNF249454", "relationship": "is"}], "GNF_hs-Origene": [{"id": "GNF041812", "relationship": "similar to"}, {"id": "GNF048990", "relationship": "similar to"}], "GNF_hs-druggable_lenti-shRNA": [{"id": "GNF082587", "relationship": "is"}, {"id": "GNF082588", "relationship": "is"}, {"id": "GNF082589", "relationship": "is"}], "GNF_hs-druggable_plasmid-shRNA": [{"id": "GNF051471", "relationship": "is"}, {"id": "GNF056237", "relationship": "is"}, {"id": "GNF060976", "relationship": "is"}], "GNF_hs-druggable_siRNA": [{"id": "GNF070593", "relationship": "is"}, {"id": "GNF070594", "relationship": "is"}], "NOVART_hs-genome_siRNA": [{"id": "GNF100194", "relationship": "is"}, {"id": "GNF139849", "relationship": "is"}]}, "refseq": {"genomic": ["NC_000016.10", "NC_060940.1", "NG_012025.2"], "protein": "NP_005242.1", "rna": "NM_005251.3", "translation": {"protein": "NP_005242.1", "rna": "NM_005251.3"}}, "reporter": {"HG-U133_Plus_2": ["214520_at", "239058_at"], "HG-U95Av2": "31698_at", "HTA-2_0": "TC16000670.hg.1", "HuEx-1_0": "3672646", "HuGene-1_1": "7997733", "HuGene-2_1": "16821660"}, "retired": 50824, "summary": "This gene belongs to the forkhead family of transcription factors which is characterized by a distinct DNA-binding forkhead domain.  The specific function of this gene has not yet been determined; however, it may play a role in the development of mesenchymal tissues. [provided by RefSeq, Jul 2008].", "symbol": "FOXC2", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1414669"}, "unigene": "Hs.436448", "uniprot": {"Swiss-Prot": "Q99958"}, "wikipedia": {"url_stub": "FOXC2"}}